CheckMate 9LA showed a 26% overall survival benefit for metastatic NSCLC patients treated with nivolumab and ipilimumab plus ...

The result is that value-based care now suffers from a branding problem. The term has come to mean everything and nothing at ...

A pair of patients with Waldenstrom’s non-Hodgkins lymphoma (NHL) remain in complete remission (CR) after 7 and 15 months ...

For patients who have chronic lymphocytic leukemia (CLL), experiencing Richter transformation with central nervous system ...

"The Great Healthcare Plan" aims to lower drug costs, reduce premiums, and enhance price transparency, with a focus on Most ...

The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...

ICHRAs were created in 2019 as an expansion of the executive order “Promoting Health Care Choice and Competition Across The United States,” signed by President Donald J. Trump in 2017. 2. They are ...

Clascoterone cream 1% plus adapalene gel 0.3% offers an effective, well-tolerated topical option for moderate to severe acne, ...

Reducing liver fat has become a central target in the development of therapies for metabolic dysfunction–associated ...

Despite HCM’s strong genetic basis, patients residing in lower-income or more socially deprived areas faced significantly ...

This interview discusses how BCMA-directed CAR T-cell therapy in multiple myeloma may be more effective when administered ...

Teclistamab plus daratumumab delivers unprecedented progression-free survival benefits over standard of care in ...